Blecher, Gabriel E <br/><br/>
Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.  [electronic resource] 

 -  CJEM  May 2012 
 - 169-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1481-8043 
<br/><br/><label>Standard No.: </label>10.2310/8000.2012.110591  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amiodarone--adverse effects<br/>Anti-Arrhythmia Agents--adverse effects<br/>Atrial Fibrillation--drug therapy<br/>Atrial Flutter--drug therapy<br/>Canada<br/>Electric Countershock--methods<br/>Female<br/>Humans<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Premedication--adverse effects<br/>Procainamide--adverse effects<br/>Propafenone--adverse effects<br/>Retrospective Studies<br/>Treatment Outcome